Hsp90 beta inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy | |
Peng, Yu-Chen; Wang, Shan; Zhang, Yong; Huang, Long-Jian; Wang, Xiao-Liang; Peng, Ying | |
2019 | |
卷号 | 21期号:9页码:905-915 |
关键词 | Hsp90 beta inhibitor epilepsy GLT-1 absence epilepsy |
ISSN号 | 1028-6020 |
DOI | 10.1080/10286020.2018.1530989 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6345773 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Peng, Yu-Chen,Wang, Shan,Zhang, Yong,et al. Hsp90 beta inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy[J],2019,21(9):905-915. |
APA | Peng, Yu-Chen,Wang, Shan,Zhang, Yong,Huang, Long-Jian,Wang, Xiao-Liang,&Peng, Ying.(2019).Hsp90 beta inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy.,21(9),905-915. |
MLA | Peng, Yu-Chen,et al."Hsp90 beta inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy".21.9(2019):905-915. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论